Institut for Biomedicin

Preben Bo Mortensen

Cannabis use, depression and self-harm: phenotypic and genetic relationships

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Karen Hodgson, King's College London, South London and Maudsley NHS Foundation Trust
  • ,
  • Jonathan R.I. Coleman, King's College London, South London and Maudsley NHS Foundation Trust
  • ,
  • Saskia P. Hagenaars, King's College London, South London and Maudsley NHS Foundation Trust
  • ,
  • Kirstin L. Purves, King's College London
  • ,
  • Kylie Glanville, King's College London
  • ,
  • Shing Wan Choi, King's College London
  • ,
  • Paul O'Reilly, King's College London, Icahn School of Medicine at Mount Sinai
  • ,
  • Gerome Breen, King's College London, South London and Maudsley NHS Foundation Trust
  • ,
  • Cathryn M. Lewis, King's College London, South London and Maudsley NHS Foundation Trust
  • ,
  • Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium

Background and Aims: The use of cannabis has previously been linked to both depression and self-harm; however, the role of genetics in this relationship is unclear. This study aimed to estimate the phenotypic and genetic associations between cannabis use and depression and self-harm. Design: Cross-sectional data collected through UK Biobank were used to test the phenotypic association between cannabis use, depression and self-harm. UK Biobank genetic data were then combined with consortia genome-wide association study summary statistics to further test the genetic relationships between these traits using LD score regression, polygenic risk scoring and Mendelian randomization methods. Setting: United Kingdom, with additional international consortia data. Participants: A total of 126 291 British adults aged between 40 and 70 years, recruited into UK Biobank. Measurements: Phenotypic outcomes were life-time history of cannabis use (including initial and continued cannabis use), depression (including single-episode and recurrent depression) and self-harm. Genome-wide genetic data were used and assessment centre, batch and the first six principal components were included as key covariates when handling genetic data. Findings: In UK Biobank, cannabis use is associated with an increased likelihood of depression [odds ratio (OR) = 1.64, 95% confidence interval (CI) = 1.59–1.70] and self-harm (OR = 2.85, 95% CI = 2.69–3.01). The strength of this phenotypic association is stronger when more severe trait definitions of cannabis use and depression are considered. Using consortia genome-wide summary statistics, significant genetic correlations are seen between cannabis use and depression [rg = 0.289, standard error (SE) = 0.036]. Polygenic risk scores for cannabis use and depression explain a small but significant proportion of variance in cannabis use, depression and self-harm within a UK Biobank target sample. However, two-sample Mendelian randomization analyses were not significant. Conclusions: Cannabis use appeared to be both phenotypically and genetically associated with depression and self-harm. Limitations in statistical power mean that conclusions could not be made on the direction of causality between these traits.

OriginalsprogEngelsk
TidsskriftAddiction
Vol/bind115
Nummer3
Sider (fra-til)482-492
Antal sider11
ISSN0965-2140
DOI
StatusUdgivet - 2020

Se relationer på Aarhus Universitet Citationsformater

ID: 175275584